Existing drug enhances muscle repair during GLP-1 weight-loss treatment in mice
The experimental companion drug preserved muscle regeneration and strength in obese mice while matching semaglutide’s fat loss, Stanford researchers said.
2 Articles
2 Articles
Research Roundup: Combating muscle loss from GLP-1s, monitoring high-risk pregnancies and reversing aging in sea squirts
The Science & Technology desk gathers a weekly digest of compelling scientific research publications and developments at Stanford. Read the latest in this week’s Research Roundup. The hidden cost of Ozempic and a possible solution GLP-1 medications like Ozempic and Wegovy have become increasingly popular among Americans seeking weight loss. Alongside fat, however, these drugs also cause patients to lose muscle, a detriment to long-term health. A…
Existing drug enhances muscle repair during GLP-1 weight-loss treatment in mice
Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn't return quickly, and muscle loss can have deleterious effects on strength, mobility, and overall health.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
